跳至主要内容
临床试验/NCT01138943
NCT01138943已完成不适用

Chlorhexidine Alcohol Base Mouthrinse Versus Chlorhexidine Formaldehyde Base Mouthrinse Efficacy on Plaque Control: Double Blind, Randomized Clinical Trials

Hôpital Militaire De Rabat1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2007年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
Plaque Index (PI)at Day 1 and Day 7.

研究概览

简要总结

The aim of the present study was to compare antiplaque effectiveness of two commercial mouthrinses: 0.12 % Chlorhexidine alcohol base (CLX-A) versus a diluted 0.1% Chlorhexidine non-alcohol base with 0.1% of Formaldehyde (CLX-F).

详细描述

Chlorhexidine (CLX) mouthrinse has been the gold standard as antiplaque solution.However, if its efficiency seems to be preserved even if the chlorhexidine concentration is bellow 0.10%, the formulation of the final product may affect the effectiveness. Thus, it can be concluded from this study that 0.12% CLX alcohol base mouthrinse is significantly more effective in inhibiting plaque than the diluted 0.1% CLX non-alcohol base containing formaldehyde mouthrinse.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 25 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • give written informed consent before entering the study
  • accept to stop tooth cleaning for a week

排除标准

  • less than 20 teeth;
  • presence of periodontal disease
  • presence of factors of plaque retention (clinically unacceptable restorations, important carious, dental overlapping, removable prosthesis, faulty fixed prosthesis, orthodontic appliances),
  • associated systemic diseases (diabetes, heart disorders, blood diseases, HIV infection),
  • use of antibiotics or other anti-inflammatory drugs during the latest months,
  • known allergy against components of mouth rinses,
  • pregnancy,

研究组 & 干预措施

Chlorhexidine alcohol-base mouthrinse

Active Comparator

干预措施: Synthodont (Drug)

non alcohol chlorhexidine mouthrinse

Experimental

干预措施: Soludent (Drug)

结局指标

主要结局

Plaque Index (PI)at Day 1 and Day 7.

时间窗: one week

The clinical trial lasted 7 days (from Day 0 to Day 7). During this period all participants abstained from all mechanical oral hygiene procedures. On Day 0, subjects were randomly distributed in three groups: two test groups and one negative control group, and were instructed to rinse twice daily with the allocated mouthrinse during the experimental period. The clinical measurement: Plaque Index (PI) was recorded on Day 1 and Day 7.

次要结局

  • Side effects(at day 7)

研究者

发起方
Hôpital Militaire De Rabat
申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Chlorhexidine Mouthrinses and Plaque Control | 临床试验